-
Maternal plasma soluble fms-like tyrosine kinase-1 and free vascular endothelial growth factor at 11 to 13 weeks of gestation in preeclampsia.
Akolekar R, Cruz JJ, Foidart JM, Munaut C, Nicolaides KH.
Prenat Diagn 2010;30:191-7. -
Maternal endothelial function and serum concentrations of placental growth factor and soluble endoglin in women with abnormal placentation.
Savvidou MD, Noori M, Anderson JM, Hingorani AD, Nicolaides KH.
Ultrasound Obstet Gynecol 2008;32:871-6. -
Physiological distribution of placental growth factor and soluble Flt-1 in early pregnancy.
Makrydimas G, Sotiriadis A, Savvidou MD, Spencer K, Nicolaides KH.
Prenat Diagn 2008;28:175-9. -
Maternal serum concentration of soluble fms-like tyrosine kinase 1 and vascular endothelial growth factor in women with abnormal uterine artery Doppler and in those with fetal growth restriction.
Savvidou MD, Yu CK, Harland LC, Hingorani AD, Nicolaides KH.
Am J Obstet Gynecol 2006;195:1668-73. -
Levels of C-reactive protein in pregnant women who subsequently develop pre-eclampsia.
Savvidou MD, Lees CC, Parra M, Hingorani AD, Nicolaides KH.
BJOG 2002;109:297-301. -
First trimester maternal serum AFP and total hCG in aneuploidies other than trisomy 21.
Spencer K, Heath V, Flack N, Ong C, Nicolaides KH.
Prenat Diagn 2000;20:635-9. -
Maternal serum alpha-fetoprotein in fetal neural tube and abdominal wall defects at 10-14 weeks of gestation.
Sebire NJ, Spencer K, Noble PL, Hughes K, Nicolaides KH.
BJOG 1997;104:849-51. -
Fetal hepatic alpha-fetoprotein mRNA expression in fetuses with trisomy 21 and 18 at 12-15 weeks gestation.
Brizot ML, Mckie AT, von-Kaisenberg CS, Farzaneh F, Nicolaides KH.
Early Hum Dev 1996;44:155-9. -
First trimester maternal serum alpha-fetoprotein in fetal trisomies.
Brizot ML, Khun P, Bersinger NA, Snijders RJM, Nicolaides KH.
Br J Obstet Gynaecol 1995;102:31-4.